Adherence to bisphosphonates and hormone replacement therapy in a tertiary care setting of patients in the CANDOO database
Adherence to bisphosphonates and hormone replacement therapy in a tertiary care setting of patients in the CANDOO database is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Adherence to bisphosphonates and hormone replacement therapy in a tertiary care setting of patients in the CANDOO database have?
Adherence to bisphosphonates and hormone replacement therapy in a tertiary care setting of patients in the CANDOO database has 92 citations in the OpenAlex counts ScholarIQ stores.
When was Adherence to bisphosphonates and hormone replacement therapy in a tertiary care setting of patients in the CANDOO database published?
Adherence to bisphosphonates and hormone replacement therapy in a tertiary care setting of patients in the CANDOO database has 2003 year in the ScholarIQ index.
What is the open-access status of Adherence to bisphosphonates and hormone replacement therapy in a tertiary care setting of patients in the CANDOO database?
Adherence to bisphosphonates and hormone replacement therapy in a tertiary care setting of patients in the CANDOO database has closed oa status in the ScholarIQ index.
What is the DOI of Adherence to bisphosphonates and hormone replacement therapy in a tertiary care setting of patients in the CANDOO database?
The DOI for Adherence to bisphosphonates and hormone replacement therapy in a tertiary care setting of patients in the CANDOO database is on the source record.
What is the PMID of Adherence to bisphosphonates and hormone replacement therapy in a tertiary care setting of patients in the CANDOO database?
The PMID for Adherence to bisphosphonates and hormone replacement therapy in a tertiary care setting of patients in the CANDOO database is on the source record.
What is the OpenAlex record for Adherence to bisphosphonates and hormone replacement therapy in a tertiary care setting of patients in the CANDOO database?
The OpenAlex for Adherence to bisphosphonates and hormone replacement therapy in a tertiary care setting of patients in the CANDOO database is on the source record.